IntroDuctIon
are currently not available. We acknowledge that for routine monitoring of APL externalization some investigators may prefer to use Annexin V, as it is faster, more convenient and does not require as high a level of specialist expertise as the method outlined herein. Thus, the methods should be considered complementary, providing distinct information that could be used in different ways to further our understanding of the biology of APL externalization on mammalian cells.
Experimental design
The approach described here is based on the use of the cellimpermeable reagent EZ-link sulfo-NHS-biotin (SNB). This reagent biotinylates primary amines, and it has been extensively used for proteomics of extracellular-facing proteins on intact cells 15 . In a similar way, it can be used to derivatize external-facing APL primary amine headgroups (NH 2 groups), leading to a mass shift of 226 a.m.u. Thus, external APLs are distinguished from internal forms through a change in chemical structure that is then measured using a sensitive and specific LC-MS/MS method (Fig. 3) .
Optimizing the approach for other cell types. When you are working with cells other than those described herein, the specific lipids to monitor using the assay must be determined by characterizing the PE and PS in the specific cells of interest. This is described in the PROCEDURE (Steps [13] [14] [15] [16] . In the case of some mammalian cells, it is anticipated that there will be a high proportion of unsaturated and plasmalogen (for PE) species as for platelets and neutrophils. Further details of how to characterize PE and PS are given in Clark et al. 4 (http://www.pnas. org/content/110/15/5875/suppl/DCSupplemental).
First, the predominant PE and PS molecular species contained in the cells of interest are characterized using MS scanning approaches. This requires the generation of a total cellular lipid extract, which is then scanned for PE and PS by MS. PS is identified by the neutral loss of 87 a.m.u. in negative ion mode, in crude lipid extracts. Specifically, PS is detected by searching for molecules that lose the characteristic headgroup of 87 a.m.u. on collision-induced dissociation. However, PE needs to be purified from other phospholipid classes before MS scanning because of the presence of isobaric and interfering ions. To do this, we analyze crude cell lipid on normal-phase HPLC, which separates according to headgroup, monitoring at 205 nm (based on unsaturated fatty acids).
A further issue when working with other cell types is the need to prevent membrane changes that might result in APL exposure in the outer plasma membrane artifactually, for example, during cellular dissociation (collagenase digestion when processing tissue samples) or during flow-assisted cell sorting using antibodies that might directly activate cells.
Generating appropriate primary and internal standards. Next, a series of biotinylated primary and internal standards that correspond to these are synthesized and standard curves are generated. Our assay uses biotinylated analogs of 1,2-dimyristoyl-sn-glycero-3-PS (DMPS) and 1,2-dimyristoyl-sn-glycero-3-PE (DMPE) as internal standards, as these are low or absent in mammalian cells. Primary biotinylated lipids for the molecular species to be quantified are also required. When a specific lipid is not commercially available, we use the most closely related lipid for quantification. A lipid with a plasmalogen bond between the sn2 fatty acid and the glycerol backbone, for example, would be used for a commercially unavailable plasmalogen species (e.g., 16:0p/20:4-PE). Similarly, a lipid with a diacyl bond in this position is used for unavailable diacyl species. See Figure 1 for structures.
Overview of the procedure. Cells (platelets and neutrophils are described herein) are isolated, activated appropriately, and then external APL species are labeled with SNB. Last, the lipids are extracted from the samples and analyzed for their biotinylated forms via LC-MS/MS. Quantification is achieved by using the standard curves. Separately, the percentage of the total APL pool externalized can be determined by comparison with samples in which total APL has been biotinylated with a cell-permeable analog, NHS-biotin.
Optimizing the method for detection of biotinylated PE and PS. When the method was first established, we undertook extensive optimization of all steps involved, including varying incubation time for labeling and quenching, and varying concentrations of both the biotinylation reagent and lysine. Extraction efficiencies were also determined for a number of solvent-solvent methods, and HPLC separation of both PE-biotin (PE-B) and PS-biotin (PS-B) species were compared across a range of reverse-phase columns and mobile phases. The detailed characterization is presented in the online supplementary data for Clark et al. 4 . The conditions presented here will be transferable to other laboratories, although it will be essential to conduct tuning on all standards for MS detection on individual instruments, as ionization potentials, temperature, etc. will differ across platforms. We include a flow diagram that demonstrates the steps involved and order of work, including timelines and options (Fig. 4) .
Applications of the method
In this protocol, we demonstrate how the method can be used to quantify PE and PS externalization to the platelet and neutrophil plasma membrane, as examples. The method is widely applicable to mechanistic studies on phospholipid translocation (e.g., the study of flippase, floppase and scramblases in several cell types), as well as characterization of membrane lipid behavior in additional important events in which phospholipid translocation is known to occur, such as apoptosis, aging, vesiculation, cell division and cell activation. Apoptosis occurs during many cellular events, including development, cancer and psychiatric disorders, thereby indicating wide potential utility of the assay. The method could be adapted to HPLC fluorescence or absorbance detection, by using an amine-reactive fluorophore or chromophore in place of SNB, several of which are commercially available for proteinlabeling studies from Pierce. As this method involves the use of MS, technical competence in this technology and access to a tandem instrument is required. Most laboratories should be able to access this through either core facilities or collaborators if it is not available in-house. Alternatively, we would collaborate with those who wish to use the assay, either to advise on setup, provide analytical standards or to run samples on our instrument in Cardiff.
Limitations
Currently, the most widely used method for determining APL exposure is annexin V-FITC flow cytometry. As described in the introduction, annexin V is a nonquantitative probe that only reports on whether a cell is positive or negative for APL exposure, but it provides no information on specific molecular species or their amounts. The primary disadvantages of the new LC-MS/MS assay versus annexin V are as follows: (i) inability of the new assay to distinguish individual cells that externalize APLs from those that do not and (ii) the inability to study cells while they are suspended in lipid-or protein-containing solutions (e.g., plasma or serum-containing tissue culture medium). Last, this method takes longer than annexin-based methods, and it requires a considerable degree of technical training and access to more expensive MS equipment. An expert in MS would easily set up the method, but a more junior researcher might require some support. We would be very happy to give advice, provide biotinylated standards or to analyze samples for researchers unable to access the technology in their own institutions, as required. 2| Evaporate 1 mg of lipid standard under a nitrogen stream and reconstitute it in 220 µl of chloroform and 110 µl of methanol in a small glass vial. Weigh ~6 mg of NHS-biotin (powder) on a weigh boat and transfer it to the vial (to give 52 mM). Vortex, add 3.3 µl of triethylamine and then incubate the mixture at room temperature for 30 min.
3| Sediment the excess NHS-biotin reagent by centrifuging at 500g for 5 min at 20 °C. Carefully transfer the solvent to a clean glass vial. 'Wash' the remaining NHS-biotin with a chloroform/methanol (2:1) solution, vortex it and then repeat the centrifugation step. Combine the solvent fractions and dry them, resuspending the biotinylated lipids in 500 µl of methanol for HPLC purification.
4| (Optional) Before purifying biotinylated standards, we recommended that a small fraction of the lipid sample be analyzed via the HPLC method to determine accurate retention times. To do this, perform
Step 5 using 5-10 µl of sample. 6| Inject 100 µl of the sample. Collect the fraction and dry it by using a RapidVap or Dryblock with a nitrogen stream at a temperature of 30 °C, and then resuspend the sample in 200 µl of methanol.
7|
Accurately weigh the glass vial that the sample is to be stored in, ensuring that the vial is clean and dry, and that you are wearing gloves at all times. Transfer 200 µl of the sample into a preweighed glass vial and dry the solvent. Reweigh the glass vial and record the difference in weight. Use a high-accuracy analytical balance or microbalance for this (for example, the Mettler Toledo XP2U).
8|
Resuspend the sample in methanol at 100 ng µl −1 , which allows simple dilution for standard curve preparation, and then store it under argon gas (or nitrogen if argon is not available) at −80 °C. MS/MS spectra and fragmentation patterns of a biotinylated PE and PS are shown for reference in Figure 5 .  pause poInt The standards can be stored for up to a year at −80 °C.
Isolation of cell samples 9|
Perform option A given below for the isolation and activation of human platelets, and perform option B for the isolation and activation of human neutrophils. Platelets can be activated to externalize APLs by using several stimuli, including thrombin, Ca 2+ ionophore (e.g., A23187) and collagen, as well as during apoptosis and in vitro aging 4 . In option A, thrombin activation is described.  crItIcal step Ensure that a brake mechanism is not used on the centrifuge, as this will disturb the separation of the cells. (iii) Gently aspirate the upper layer of platelet-rich plasma with a 3-ml plastic Pasteur pipette into a 50-ml plastic tube, and then centrifuge this at 900g for 10 min at 20-22 °C to pellet the platelets. Discard the red-cell lower phase. Aspirate the platelet-poor plasma and discard it. Resuspend the cell pellet in 10 ml of ACD in Tyrode's buffer (ACD:Tyrode's 1:9, vol/vol). (iv) Centrifuge the mixture at 800g for 10 min at 20-22 °C. Aspirate the supernatant and discard it. Carefully resuspend the pellet in 2 ml of Tyrode's buffer. At this point, count the platelets, using either a hemocytometer or a Coulter counter, and then dilute them to a concentration of 2 × 10 8 platelets per ml in Tyrode's buffer. (v) Allow the platelets to rest for 20 min at room temperature before further manipulation, but for no longer than 2 h. (vi) Activation using thrombin. Incubate 200 µl of 2 × 10 8 platelets per ml with 1 mM CaCl 2 at 37 °C in a water bath for 10 min. Add 0.2 U ml −1 thrombin and incubate the mixture for 30 min. Proceed to biotinylation of externalized APLs (Step 17). (B) Isolation of human neutrophils and induction of apoptosis • tIMInG 2-2.5 h (i) Draw venous blood through a 21-gauge needle from healthy volunteers (who have not taken nonsteroidal antiinflammatory drugs for at least 14 d), through a butterfly needle into a syringe. Immediately mix whole blood with 2.8% (wt/vol) citrate and Hetasep (Stemcell Technologies) at a blood:citrate:Hetasep ratio of 10:2:2, e.g., 20 ml of blood into 4 ml of 2.8% (wt/vol) citrate and 4 ml of Hetasep.  crItIcal step Neutrophils are sensitive to shear stress, physical deformation, negatively charged surfaces such as glass or polystyrene and contaminating microorganisms. To avoid activation, do not pipet vigorously with small-bore pipette tips or generate bubbles during handling. Reagents and equipment should be sterile, and procedures should be performed under aseptic technique for all procedures described. Exposure to bacteria or bacterially derived contaminants can alter neutrophil life span and confound studies of cell death. However, handling of samples over short intervals (such as for lipid profiling) can be undertaken on the bench because contamination will be minor.  crItIcal step To prevent activation of the neutrophils, ensure that you are gentle (no shaking or vortexing of cells), and maintain them on ice at all times before stimulation. Resuspend very gently after centrifugation. (ii) Allow this mixture to settle under gravity for 35-50 min at room temperature (until a distinct upper layer of at least 50% of the volume is seen). This will be easily visible, as the lower layer contains the majority of red cells. Recover the upper, red cell-deficient layer. Underlay with Lymphoprep (Axis-Shield) with an erythrocyte-poor blood: Lymphoprep ratio of 2:1 (e.g., 10 ml of blood with 5 ml of Lymphoprep). (iii) Centrifuge the mixture at 800g for 20 min at 4 °C.  crItIcal step Ensure that a brake mechanism is NOT used on the centrifuge, as this will disturb the separation of the cells. (iv) Carefully use a 3-ml plastic Pasteur pipette to remove and discard the monocytic cells at the interface (a white layer between two more transparent phases), without allowing them to mix with the pelleted cells. Next, remove all remaining plasma and Lymphoprep. Recover the pelleted cells with 2 ml of 0.4% (wt/vol) citrate, transfer them to a clean tube and dilute to a 10-ml volume with 0.4% (wt/vol) citrate.  crItIcal step Ensure that the neutrophils and erythrocytes in the pellet do not mix with the monocytic cells that were at the interface and that will be stuck to the side of the tube. (v) Centrifuge the mixture at 400g for 10 min at 4 °C. Aspirate the supernatant and discard it. Lyse red cells by hypotonic shock. Resuspend the cells in 3 ml of ice-cold hypotonic saline with a 3-ml plastic Pasteur pipette, adding the saline slowly down the side of the tube, swirling gently. After 35-45 s, restore osmolality by adding 3 ml of ice-cold hypertonic saline and make up the volume to 10 ml with PBS. (vi) Centrifuge the mixture at 400g for 10 min at 4 °C and repeat the hypotonic shock if red cells are visible in the pellet.
Finally, resuspend in 1 ml of Krebs buffer (see Reagent Setup) and dilute to a concentration of 2 × 10 7 neutrophils per ml.  crItIcal step In the absence of stromal cells or an inflammatory environment, neutrophils will begin to spontaneously apoptose in culture after only a few hours. Many cells will be apoptotic by 24 h. Serum must not be included, as the biotinylation reagents will be consumed by reaction with primary amines in these proteins. up to 24 h. At each time point, harvest the cells by gently pipetting with a 3-ml plastic Pasteur pipette for 10 s before removing 200 µl into an Eppendorf tube. Proceed to biotinylation of externalized APLs (Step 17).
extraction of native lipids with acidified hexane:isopropanol • tIMInG ~1 h with 1-2 h of drying time  crItIcal To determine which PE and PS species to monitor for externalization, the primary molecular species need to be first characterized in the cells of interest. Two samples are isolated: a PE sample and a PS sample. The PE sample requires an additional purification and fractionation step using normal-phase chromatography. This is because there are a number of isobaric lipids in the PE sample, and fractionation makes it easier to tell them apart. Fractionation of PE is described in Steps 13-15.
10|
Prepare a labeled glass extraction tube with 2.5 ml of solvent mix 2. Add 1 ml of unactivated, freshly prepared cells (from Step 9) to the glass extraction tubes. For platelets, typically this contains 2 × 10 8 cells ml. For neutrophils, use 1 × 10 6 per ml.
11|
Vortex the mixture thoroughly for 1 min. Add 2.5 ml of hexane and vortex it thoroughly for 1 min. Centrifuge the samples at 500g for 5 min at 20-22 °C. Carefully remove the upper layer with a glass Pasteur pipette and transfer it to a clean, labeled glass vial. Re-extract the lower layer by adding a further 2.5 ml of hexane and vortexing it thoroughly for 1 min.
12|
Repeat the centrifugation step and again remove the upper hexane layer and combine it with the previous one. Dry the samples by using either nitrogen gas or a vacuum extraction system, and then resuspend them in 100 µl of methanol. Store the samples under argon gas (or nitrogen if argon is not available) at −80 °C until further analysis.  pause poInt The samples can be stored for up to 1 week before analysis.
Fractionation of lipid species to purify pe • tIMInG ~1 d  crItIcal Undertake purification of PE from cell samples of interest to generate a fraction that can be used for characterizing the major PE species, as follows. Ensure that HPLC-grade solvents are used, as lower grades can absorb markedly in the low UV. Note that retention times can vary a little on normal-phase chromatography, but not substantially between runs.
13| Set up normal-phase HPLC with a Spherisorb S5W 5-µm column (150 × 4.6 mm) with a guard column, at the following conditions: temperature, 22 °C; flow rate, 1.5 ml min −1 ; gradient elution, 50% mobile phase B to 100% mobile phase B (A, hexane:isopropanol 3:2; B, mobile phase A:water, 94.5:5.5) over 25 min before re-equilibration to 50% B; UV absorbance, 205 nm.
14| Inject brain or egg PE (~1-10 µg) and determine the retention time (PE; typically 5.5 min). Ensure that no carry-over from the standard is evident by injecting a blank sample consisting of mobile phase. Dry down the lipid sample under nitrogen stream and resuspend it in mobile phase at the starting composition.
15|
Inject the sample and collect the fractions corresponding to the elution time for PE. A typical trace of elution is shown in Figure 6a . Dry the sample by using a RapidVap or Dryblock with nitrogen stream at a temperature of 30 °C, and resuspend it in 100 µl of methanol. Store it under argon gas (or nitrogen if argon is not available) at −80 °C until LC-MS analysis.  pause poInt The samples can be stored for up to a week before analysis. characterization of cellular pe and ps molecular species by direct-infusion Ms • tIMInG ~1 h 16| Determination of PS is achieved by neutral-loss MS/MS of crude lipid extracts for the PS headgroup (87 a.m.u.) (Fig. 6b) , whereas PE is determined by MS scanning of the purified PE fraction in positive-or negative-ion mode (Fig. 6c) , as described in the Experimental design section. A heavily diluted extract should initially be used for direct infusion (e.g., injection of the lipid into the MS source using a syringe pump) to prevent source contamination. Once putative structural assignments are generated, they need to be verified by LC-MS/MS, wherein PE and PS are monitored in negative mode by using the transition corresponding to parent→fatty acid carboxylate anion. Ions identified as PEs are circled (Fig. 6c) . Follow option A and option B for PS and PE characterization, respectively. (a) ps characterization (i) Dilute the unfractionated lipid extract with methanol. To ensure that the MS process is not contaminated by concentrated lipid extracts, start with 1:1,000 and gradually work up 10×, if necessary, until a signal is detected. (ii) Use a syringe pump to inject into the mass spectrometer at a rate of 10 µl min −1 . Scan for negative neutral loss of 87 a.m.u. from m/z 600-1,000. (iii) On a 4000 Q-Trap, acquire spectra by using a 2-s scan time and the following settings: Q1 unit resolution, Q3 unit resolution, MR pause 5 ms, MCA-Yes, step size 0.10 a.m.u., CUR 10, IS -4500, TEM 0, GS1 12, GS2 0, ihe On, CAD medium, DP -40, EP -10, CE -30, CXP -6.
(B) pe characterization (i) For PE, dilute lipid into methanol, starting at 1:1,000, but working up to more concentrated samples if it is below the limit of detection, and use a syringe pump to inject into the mass spectrometer at a rate of 10 µl min −1 . (ii) Scan in positive MS mode from 600-900 a.m.u. using settings as follows on a 4000 Q-Trap: unit resolution, MR pause 5 ms, step size 0.1 a.m.u., CUR 10, IS 4500, TEM, GS1 12, GS2 0, ihe On, DP 120, EP 10. (iii) Generate putative structural assignments by using either Lipid Calculator (http://pharmacology.ucdenver.edu/lipidcalc/) or LIPID MAPS (http://www.lipidmaps.org/resources/tutorials/databases.html). The assignment of the ions in platelet PE is described in more detail in Clark et al. 4 . (iv) Set up a reverse-phase HPLC system with a Luna C18 3-µm (150 × 2 mm) column and conditions at 22 °C as follows: flow rate, 0. stimulation to undergo activation or apoptosis. (Steps 26-28 describe the procedure for determining the total concentration of APL in the cell membranes by labeling with a cell-permeable reagent.).
17|
Remove the sample from the water bath or incubator and add 86 µl of EZ-link SNB.
18|
Incubate the mixture at room temperature for 10 min with occasional gentle inversion.
19|
Add 72 µl of lysine.
20|
Incubate the mixture at room temperature for a further 10 min with occasional gentle inversion. Add 10 µl of DMPE-B (1 ng µl −1 ) and DMPS-B (1 ng µl −1 ) internal standards, thus giving a final concentration of 10 ng µl −1 of each standard. 21| Extract lipids as described below (do not pause; continue straight to the next section).
Modified Bligh and Dyer extraction of biotinylated lipids
• tIMInG ~1 h with 1-2 h for drying 22| In advance, prepare a labeled glass extraction tube for each sample containing 1.5 ml of solvent mix 1 (ref. 16 ). Add the sample to the extraction tube, followed by 42 µl of Tyrode's buffer, to yield a total volume of 400 µl aqueous and a 1:3.75 ratio of aqueous sample:solvent mix 1. If you are using a different volume, then maintain the ratio of aqueous:solvent to ensure efficient extraction.
23|
Vortex the mixture thoroughly for 1 min. Add 0.5 ml of chloroform and vortex it thoroughly for a further minute. Add 0.5 ml of HPLC-grade water and again vortex thoroughly for 1 min. Centrifuge the samples at 500g for 5 min at 20-22 °C.
24|
Carefully remove the lower layer with a glass Pasteur pipette and transfer it to a clean, labeled glass vial. Dry the samples using a RapidVap or Dryblock with a nitrogen stream at a temperature of 30 °C.  crItIcal step To limit sample degradation, do not overheat the samples in the drying process. 
25|
Resuspend the sample in 100 µl of methanol and store it under argon gas (or nitrogen if argon is not available) at −80 °C until LC-MS analysis.  pause poInt Samples can be stored for up to 1 week before analysis.
Biotinylation of total cellular lipids • tIMInG ~30 min  crItIcal In Steps 26-28, all of the APLs in the samples are biotinylated using the cell-permeable analog NHS-biotin (NB). Externalized APL is then calculated as a fraction of the total, to give percentage.
26|
Activate the cells or stimulate them to undergo apoptosis, as described above, but with samples of 400 µl in total volume (keep the cell concentration as previously specified). After activation, remove the samples from the water bath and split them into two Eppendorf tubes with equal volumes.
27|
To one half, biotinylate extracellular APLs as described in Steps 17-21. To the other half, add 20 µl of 20 mM NB (6.82 mg ml −1 ) in DMSO and incubate it at 22 °C for 10 min. 
